Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.7288
-0.0241 (-3.20%)
Mar 31, 2025, 2:27 PM EDT - Market open

Vor Biopharma Statistics

Total Valuation

Vor Biopharma has a market cap or net worth of $90.99 million. The enterprise value is $33.90 million.

Market Cap 90.99M
Enterprise Value 33.90M

Important Dates

The last earnings date was Thursday, March 20, 2025, after market close.

Earnings Date Mar 20, 2025
Ex-Dividend Date n/a

Share Statistics

Vor Biopharma has 124.85 million shares outstanding. The number of shares has increased by 2.25% in one year.

Current Share Class 124.85M
Shares Outstanding 124.85M
Shares Change (YoY) +2.25%
Shares Change (QoQ) +2.28%
Owned by Insiders (%) 31.91%
Owned by Institutions (%) 12.20%
Float 39.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.97
P/TBV Ratio 0.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.33.

Current Ratio 5.19
Quick Ratio 4.94
Debt / Equity 0.33
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -94.52% and return on invested capital (ROIC) is -48.11%.

Return on Equity (ROE) -94.52%
Return on Assets (ROA) -44.42%
Return on Invested Capital (ROIC) -48.11%
Return on Capital Employed (ROCE) -97.51%
Revenue Per Employee n/a
Profits Per Employee -$735,308
Employee Count 159
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.93% in the last 52 weeks. The beta is -0.41, so Vor Biopharma's price volatility has been lower than the market average.

Beta (5Y) -0.41
52-Week Price Change -65.93%
50-Day Moving Average 1.16
200-Day Moving Average 0.99
Relative Strength Index (RSI) 30.48
Average Volume (20 Days) 291,685

Short Selling Information

The latest short interest is 1.33 million, so 1.06% of the outstanding shares have been sold short.

Short Interest 1.33M
Short Previous Month 1.45M
Short % of Shares Out 1.06%
Short % of Float 3.41%
Short Ratio (days to cover) 3.72

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -121.19M
Pretax Income -118.09M
Net Income -116.91M
EBITDA -117.66M
EBIT -121.19M
Earnings Per Share (EPS) -$1.70
Full Income Statement

Balance Sheet

The company has $91.93 million in cash and $31.83 million in debt, giving a net cash position of $60.10 million or $0.48 per share.

Cash & Cash Equivalents 91.93M
Total Debt 31.83M
Net Cash 60.10M
Net Cash Per Share $0.48
Equity (Book Value) 96.66M
Book Value Per Share 0.77
Working Capital 77.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$99.66 million and capital expenditures -$229,000, giving a free cash flow of -$99.89 million.

Operating Cash Flow -99.66M
Capital Expenditures -229,000
Free Cash Flow -99.89M
FCF Per Share -$0.80
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.25%
Shareholder Yield -2.25%
Earnings Yield -124.38%
FCF Yield -106.26%

Analyst Forecast

The average price target for Vor Biopharma is $9.43, which is 1,193.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.43
Price Target Difference 1,193.91%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1